Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction

NCT05150054 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT05150054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05150054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnetocardiography as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Completed
Start date
January 14, 2022
Completion date
July 30, 2023
Enrollment
93 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

coronary microvascular dysfunction, ischemic non-obstructive coronary artery disease